157 related articles for article (PubMed ID: 17285360)
1. Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling.
Hazra A; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):333-54. PubMed ID: 17285360
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacokinet Biopharm; 1998 Dec; 26(6):619-48. PubMed ID: 10485078
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1998 Jun; 26(3):289-317. PubMed ID: 10098101
[TBL] [Abstract][Full Text] [Related]
4. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.
Xu ZX; Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1995 Apr; 23(2):163-81. PubMed ID: 8719235
[TBL] [Abstract][Full Text] [Related]
5. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
Ayyar VS; Sukumaran S; DuBois DC; Almon RR; Qu J; Jusko WJ
J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):557-575. PubMed ID: 29704219
[TBL] [Abstract][Full Text] [Related]
6. Meta-modeling of methylprednisolone effects on glucose regulation in rats.
Fang J; Sukumaran S; Dubois DC; Almon RR; Jusko WJ
PLoS One; 2013; 8(12):e81679. PubMed ID: 24312573
[TBL] [Abstract][Full Text] [Related]
7. The responses of rat liver glucocorticoid receptors and genes for tyrosine aminotransferase, alpha-2-macroglobulin and gamma-fibrinogen to adrenalectomy-, dexamethasone- and inflammation-induced changes in the levels of glucocorticoids and proinflammatory cytokines.
Sevaljević L; Isenović E; Vulović M; Macvanin M; Zakula Z; Kanazir D; Ribarac-Stepić N
Biol Signals Recept; 2001; 10(5):299-309. PubMed ID: 11490095
[TBL] [Abstract][Full Text] [Related]
8. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.
Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
Ayyar VS; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):45-57. PubMed ID: 28729456
[TBL] [Abstract][Full Text] [Related]
10. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment.
DuBois DC; Xu ZX; McKay L; Almon RR; Pyszcznski N; Jusko WJ
J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):237-43. PubMed ID: 7577705
[TBL] [Abstract][Full Text] [Related]
11. Gene arrays and temporal patterns of drug response: corticosteroid effects on rat liver.
Almon RR; DuBois DC; Pearson KE; Stephan DA; Jusko WJ
Funct Integr Genomics; 2003 Dec; 3(4):171-9. PubMed ID: 12928814
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glucocorticoid receptors during adaptive liver growth.
Thottassery JV; Yarbrough JD
Am J Physiol; 1991 Apr; 260(4 Pt 1):G603-9. PubMed ID: 1673321
[TBL] [Abstract][Full Text] [Related]
13. Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.
Hazra A; Pyszczynski NA; DuBois DC; Almon RR; Jusko WJ
Pharm Res; 2008 Apr; 25(4):769-80. PubMed ID: 17674160
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the hepatic glucocorticoid response to mirex treatment.
Brown LD; Wilson DE; Yarbrough JD
Toxicol Appl Pharmacol; 1988 Feb; 92(2):203-13. PubMed ID: 2893471
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxal 5'-phosphate modulates expression of cytosolic aspartate aminotransferase gene by inactivation of glucocorticoid receptor.
Oka T; Komori N; Kuwahata M; Hiroi Y; Shimoda T; Okada M; Natori Y
J Nutr Sci Vitaminol (Tokyo); 1995 Jun; 41(3):363-75. PubMed ID: 7472680
[TBL] [Abstract][Full Text] [Related]
16. Abnormal regulation of hepatic glucocorticoid receptor mRNA and receptor protein distribution in the obese Zucker rat.
Jenson M; Kilroy G; York DA; Braymer D
Obes Res; 1996 Mar; 4(2):133-43. PubMed ID: 8681046
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.
Sukumaran S; Jusko WJ; DuBois DC; Almon RR
J Pharmacol Exp Ther; 2011 Jun; 337(3):734-46. PubMed ID: 21398515
[TBL] [Abstract][Full Text] [Related]
18. Retinoids modulate the binding capacity of the glucocorticoid receptor and its translocation from cytosol to nucleus in liver cells.
Audouin-Chevallier I; Pallet V; Coustaut M; Alfos S; Higueret P; Garcin H
J Steroid Biochem Mol Biol; 1995 Apr; 52(4):321-8. PubMed ID: 7734399
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.
Haughey DB; Jusko WJ
J Pharmacokinet Biopharm; 1992 Aug; 20(4):333-55. PubMed ID: 1362219
[TBL] [Abstract][Full Text] [Related]
20. Second generation model for prednisolone pharmacodynamics in the rat.
Nichols AI; Boudinot FD; Jusko WJ
J Pharmacokinet Biopharm; 1989 Apr; 17(2):209-27. PubMed ID: 2571711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
